Details of the Drug Formulations

General Information of Drug (ID: DMNQXV8)

Drug Name
LGX818 Drug Info
Synonyms Encorafenib; 1269440-17-6; LGX-818; Encorafenib (LGX818); UNII-8L7891MRB6; LGX 818; 8L7891MRB6; Encorafenib [USAN:INN]; LGX-818(Encorafenib)
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Approved [1]
Cross-matching ID
PubChem CID
50922675
CAS Number
1269440-17-6
TTD ID
D0TK7R
INTEDE ID
DR0578
ACDINA ID
D01046

Full List of Drug Formulations Containing This Drug

Encorafenib 75 mg capsule
Company Formulation ID FDA Description
Array Biopharma F23152 Copovidone; Poloxamer 188; Microcrystalline Cellulose; Succinic Acid; Crospovidone; Colloidal Silicon Dioxide; Magnesium Stearate (Vegetable Origin); Gelatin; Titanium Dioxide; Iron Oxide Red; Iron Oxide Yellow; Ferrosoferric Oxide; Pharmaceutical Glaze; Ferrosoferric Oxide; Propylene Glycol
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.